Steven Reed
About Steven Reed
Steve Reed, Co-Founder & CEO
Steve Reed holds prominent positions as Co-Founder and CEO in various biotechnology ventures. Notably, he co-founded Corixa Corporation, Immune Design Corp., and Afrigen Biologics. His leadership roles spanned these companies until 2019. Reed's contributions include directing research and overseeing the strategic management of these enterprises.
Educational Background of Steve Reed
Steve Reed earned his PhD in Microbiology and Immunology from the University of Montana in 1979. His academic journey has equipped him with specialized knowledge and expertise that underpin his work in the fields of diagnostics, vaccines, and therapeutics.
Research and Academic Positions
Steve Reed began his career with notable appointments including Scientist of the National Institute of Amazon Research in Manaus, Brazil. He later joined Cornell University Medical College as an Assistant Professor of Medicine in 1980, and managed the Cornell-Bahia program in International Medicine in Brazil. He also holds academic appointments as Adjunct Professor of Medicine at Cornell University and Research Professor of Pathobiology at the University of Washington.
Steve Reed's Work and Contributions
Steve Reed's work includes founding the Infectious Disease Research Institute (IDRI) in 1993 and serving in various roles until 2019. He also worked at the Seattle Biomedical Research Institute starting in 1984. Reed’s research primarily focuses on diagnostics, vaccines, and therapeutics. He has received over $140 million in grants from organizations such as NIH, BARDA, DARPA, and the Gates Foundation.
Publications and Patents by Steve Reed
Steve Reed has an extensive portfolio of scholarly work including more than 400 original publications, 36 book chapters and reviews, and 109 issued patents. His research has significantly contributed to the fields of adjuvants, cancer, and infectious diseases, reflecting his deep expertise and innovative contributions.